secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0001193125-23-277417
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellevue Life Sciences Acquisition Corp. extends business combination deadline to Feb 14, 2024; 3.4M shares redeemed
--------------------------------------------------------------------------------

- Stockholders approved extension of business combination deadline from Nov 14, 2023 to Feb 14, 2024; board may further extend to May 14, 2024.
- 3,432,046 shares (~38%) tendered for redemption; $180,000 deposited into trust for first extension.
- Charter amendment filed with Delaware Secretary of State effective Nov 9, 2023.
- Trust agreement amended to allow extensions; monthly extension payments of up to $60k or $0.026/share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000119312523277417/0001193125-23-277417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000119312523277417/d891511d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-277417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer